FRIDAY, Aug. 26, 2016 (HealthDay News) -- Adding extra drugs to chemotherapy doesn't benefit patients with a rare type of bone cancer, according to a new study.
www.stltoday.com - RSS Results in lifestyles* of type article, St. Louis Post-Dispatch: Living
Fri, 08/26/2016 - 6:00am